Canton Strategic Holdings, Inc.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting companyEmerging growth company
State of Incorporation DE
Business Address 1200 ROUTE 22 EAST, BRIDGEWATER, NJ, 08807
Mailing Address 34 SHREWSBURY AVE, RED BANK, NJ, 07701
Phone 302-743-2995
Fiscal Year End 1231
EIN 842642541
Financial Overview
FY2025
$519.15M
Total Assets
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 10-K Annual financial report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 8-K Current report of material events | March 3, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 3, 2026 | View on SEC |
| 8-K Current report of material events | February 18, 2026 | View on SEC |
| 3 Initial insider ownership report | February 11, 2026 | View on SEC |
| 3 Initial insider ownership report | February 11, 2026 | View on SEC |
| 3 Initial insider ownership report | February 11, 2026 | View on SEC |
| 3 Initial insider ownership report | February 11, 2026 | View on SEC |
Annual Reports
10-K March 31, 2026
- Pivoted from biotech to a digital asset treasury focused on 'Canton Coin' (CC) validation.
- Holds $42 million in digital assets, representing 85% of the total treasury.
Material Events
8-K Legal Issue January 15, 2026
High Impact
- Tharimmune is actively taking steps to regain Nasdaq compliance regarding board independence.
- A Special Meeting of Stockholders is scheduled for January 30, 2026, to elect two new independent directors.
Related Companies
Companies in the same industry (SIC: 2834)
NERVGEN PHARMA CORP.
NGEN Pharmaceutical Preparations
Connect Biopharma Holdings Ltd
CNTB Pharmaceutical Preparations
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
LIXT Pharmaceutical Preparations
TuHURA Biosciences, Inc./NV
HURA Pharmaceutical Preparations
BIOHARVEST SCIENCES INC.
BHST Pharmaceutical Preparations
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.